CITADEL ADVISORS LLC

Holdings History for BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX)

Symbol: BCTX on Nasdaq
Investment type: Equity / Common Shares, no par value per share (the "Shares")
Latest Disclosed Shares Owned: 717,198 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Kenneth Griffin ownership in BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares") (BCTX)

23 Jan 2026 - Kenneth Griffin has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 717,198 shares of BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares") (BCTX). This represents 10% ownership of the company. This is the first filing by CITADEL ADVISORS LLC disclosing ownership of BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares") (BCTX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Kenneth Griffin	10%		$5,119,574	717,198			$7.14	13G	15 Jan 2026	23 Jan 2026, 18:59

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025			-0%	$0	0	-11,055	-100%	$4.10	Q4 2025
30 Sep 2025		0%	+0%	$121,605	11,055	+11,055	NEW	$11.00	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.